about
Acanthosis nigricans in the head and neck region.The long term health consequences of polycystic ovary syndrome.Hyperlipidaemia in hyperuricaemia and gout.Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women.Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.Association of abdominal obesity with atherosclerosis in type 2 diabetes mellitus (T2DM) in Korea.CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up.Comparison of oral and intravenous glucose tolerance test derived sensitivity and secretory indices in obese adolescents.Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.Effects of pioglitazone in familial combined hyperlipidaemia.The IGF-I/IGFBP system in congenital partial lipodystrophy.Vitamin A (retinol) status of first nation adults with non-insulin-dependent diabetes mellitus.
P2860
Q33950172-A25821D5-C884-4316-9E66-B87AF3DD07B0Q34105196-35B9E891-5CA7-4C00-BF20-BA50BB257E7AQ35548133-37DA8F5A-1BA8-4EEF-886A-8D513A05871DQ35549437-AAA20311-CEC1-431F-AABE-14D518655A69Q36249402-6A972B5F-7F57-4BEC-9692-28D55E28629CQ36283807-BAF8CB0A-26BE-4D67-B395-C0D1D9614056Q36507641-659A0B36-0079-411F-AF4F-309AE7E38102Q36966160-2A1F8295-D358-4D3D-A8C5-2769440FC598Q43265725-1C96B9DD-8952-4FBF-B9C1-89E7966A36CEQ45777529-23CFAB4A-C11C-4375-968E-0453A3262250Q46529002-780F3D48-6F73-46D6-9532-8872BFA6F5B0Q46675071-54118BA1-8142-40B4-8616-47DD2161145DQ46841591-BE204EF1-1BE9-4CD4-9036-359C9BFA6191Q51565854-81779630-05CF-44DC-AA73-09C8D4B63FB0Q51577118-91C4F5E9-9BAE-4609-B0F0-B224A34FF335
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Clinical implications of insulin resistance syndromes.
@en
type
label
Clinical implications of insulin resistance syndromes.
@en
prefLabel
Clinical implications of insulin resistance syndromes.
@en
P1476
Clinical implications of insulin resistance syndromes.
@en
P2093
Davidson MB
P304
P356
10.1016/S0002-9343(99)80191-0
P407
P577
1995-10-01T00:00:00Z